{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-2177"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-2177","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"VIRUS-LIKE PARTICLE VACCINE MANUFACTURING FROM YEAST","abstract":"Influenza virus has an intrinsic nature to undergo mutations. Hence, there have been struggles to combat this disease since the time when the worst influenza pandemic first hit in 1918. Vaccines have proved to be effective in controlling the spread of the influenza A virus by providing herd immunity. However, the contemporary design of influenza A virus based on egg and cell-culture is not efficient in tackling influenza A virus transformation. Virus-like particles (VLPs) have established themselves as a potental platform for future vaccine candidates. VLPs have all the credentials to supplant contemporary vaccine designs without compromising on immunogenicity. For expression of VLPs, yeast has all the definitive potential to develop new-generation influenza A vaccines. This report describes how to use Hansenula polymorpha, a yeast, to make VLPs of influenza H1N1 virus.","abstract_html":"Influenza virus has an intrinsic nature to undergo mutations. Hence, there have been struggles to combat this disease since the time when the worst influenza pandemic first hit in 1918. Vaccines have proved to be effective in controlling the spread of the influenza A virus by providing herd immunity. However, the contemporary design of influenza A virus based on egg and cell-culture is not efficient in tackling influenza A virus transformation. Virus-like particles (VLPs) have established themselves as a potental platform for future vaccine candidates. VLPs have all the credentials to supplant contemporary vaccine designs without compromising on immunogenicity. For expression of VLPs, yeast has all the definitive potential to develop new-generation influenza A vaccines. This report describes how to use Hansenula polymorpha, a yeast, to make VLPs of influenza H1N1 virus.","abstract_has_math":false,"creators":["Ananya, Ananya"],"institution":null,"degree_name":"Master of Science in Chemical Engineering (MS)","degree_level":"Open Access Master's Report","degree_discipline":"Department of Chemical Engineering","degree_department":null,"school":null,"contributors":["Caryn Heldt"],"advisors":[],"committee_chairs":[],"committee_members":["Rebecca Ong","Timothy Eisele"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:18:10Z","subjects":["Chemical Engineering"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/1065"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/1065","href":"https://digitalcommons.mtu.edu/etdr/1065","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/1065","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/1065","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-2177","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Caryn Heldt"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Rebecca Ong","Timothy Eisele"]},{"key":"dc:creator","label":"Author","values":["Ananya, Ananya"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2020-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Chemical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Master's Report"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Chemical Engineering (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Chemical Engineering"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/1065","https://digitalcommons.mtu.edu/etdr/1065"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Influenza virus has an intrinsic nature to undergo mutations. Hence, there have been struggles to combat this disease since the time when the worst influenza pandemic first hit in 1918. Vaccines have proved to be effective in controlling the spread of the influenza A virus by providing herd immunity. However, the contemporary design of influenza A virus based on egg and cell-culture is not efficient in tackling influenza A virus transformation. Virus-like particles (VLPs) have established themselves as a potental platform for future vaccine candidates. VLPs have all the credentials to supplant contemporary vaccine designs without compromising on immunogenicity. For expression of VLPs, yeast has all the definitive potential to develop new-generation influenza A vaccines. This report describes how to use Hansenula polymorpha, a yeast, to make VLPs of influenza H1N1 virus."]},{"key":"dc:title","label":"Title","values":["VIRUS-LIKE PARTICLE VACCINE MANUFACTURING FROM YEAST"]}]}],"canonical_facts":{"dc:contributor":["Caryn Heldt"],"dc:contributor.committeemember":["Rebecca Ong","Timothy Eisele"],"dc:creator":["Ananya, Ananya"],"dc:date.created":["2020-01-01T08:00:00Z"],"dc:description.abstract":["Influenza virus has an intrinsic nature to undergo mutations. Hence, there have been struggles to combat this disease since the time when the worst influenza pandemic first hit in 1918. Vaccines have proved to be effective in controlling the spread of the influenza A virus by providing herd immunity. However, the contemporary design of influenza A virus based on egg and cell-culture is not efficient in tackling influenza A virus transformation. Virus-like particles (VLPs) have established themselves as a potental platform for future vaccine candidates. VLPs have all the credentials to supplant contemporary vaccine designs without compromising on immunogenicity. For expression of VLPs, yeast has all the definitive potential to develop new-generation influenza A vaccines. This report describes how to use Hansenula polymorpha, a yeast, to make VLPs of influenza H1N1 virus."],"dc:identifier":["10.37099/mtu.dc.etdr/1065","https://digitalcommons.mtu.edu/etdr/1065"],"dc:subject":["Chemical Engineering"],"dc:title":["VIRUS-LIKE PARTICLE VACCINE MANUFACTURING FROM YEAST"],"thesis:degree_discipline":["Department of Chemical Engineering"],"thesis:degree_level":["Open Access Master's Report"],"thesis:degree_name":["Master of Science in Chemical Engineering (MS)"]},"updated_at":"2026-11-19T08:18:10Z"}